ABSTRACT An interleukin 2-independent murine T cell line (BFS) was isolated that produced immune interferon after stimulation with phorbol 12-myristate 13-acetate. The BFS cell line did not produce detectable levels ofinterleukin 1, interleukin 2, B cell growth factor, macrophage-granulocyte colony-stimulating factor, macrophage-activating factor, or T cell replacing factor. Maximal interferon was induced 48 hr after stimulation with phorbol myristate acetate at 10-100 ng/ml. Production of interferon by phorbol myristate acetate-stimulated BFS cell cultures was synergistically increased by the addition of EL4 thymoma cell culture supernatants. BFS-derived interferon activity was sensitive to pH 2 treatment and was neutralized with antiserum to immune interferon but was resistant to heating at 56WC and to treatment with antiserum to type I interferon. In addition, the interferon activity was sensitive to trypsin but resistant to RNase. BFS-derived interferon had an apparent molecular weight of 48,000 and a pI of 5.5-6.0. Each of these properties is consistent with the conclusion that the BFS cell line produces immune interferon after stimulation with phorbol myristate acetate.
Biochemical and biological characterization of murine a and [3 interferon (IFN) has been facilitated by the identification ofcell lines producing these molecules (1) . In contrast, antigen-or lectin-stimulated spleen cell culture supernatants have been the required source of immune IFN (IFN-y). The use of these culture supernatants as a source of IFN-y is limited by the expense of utilizing large numbers of animals. Such spleen cell culture supernatants also contain a plethora ofother lymphokine activities, which can confuse the assignment of a biological activity to a particular lymphokine.
Several recent developments have facilitated the identification of a cell line capable ofproducing IFN-y. Marcucci et aL (2) recently reported that a number of interleukin 2 (IL-2)-dependent murine T cell clones produced IFN-y after stimulation with either phytohemagglutinin or concanavalin A (Con A). In addition, Nathan et aL (3) and Pang et aL (4) have reported that phorbol 12-myristate 13-acetate (PMA) either alone or in combination with mitogen or anti-T cell monoclonal antibody enhanced IFN-'y production by a human T-lymphoblast cell line and human peripheral blood T cells.
Our laboratory has routinely utilized an IL-2-dependent T cell line (CT 6) for measuring levels of IL-2 in culture supernatants. We have recently isolated a subline of CT 6 cells (BFS) that was selected by independence of IL-2 for growth and that produces IFN-'y after stimulation with PMA. In this study we report experiments that characterize the BFS cell line, describe various biochemical properties of BFS-derived IFN-y, and examine the BFS 
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Proc. Natl. Acad'. Sci culture supernatants did not appear to contribute to the antiviral activity because PMA-treated CT 6 cell supernatants were not active in this regard. In addition, control supernatants containing PMA but no cells also possessed no antiviral effects (data not shown).
The results in Table 2 show that maximal IFN activity was detected 48 hr after stimulation of BFS cells with PMA. By 72 hr of incubation, the level of detectable IFN activity in the culture supernatant was reduced.
Characteristics of BFS IFN. Initial studies established that pretreatment of the L929 target cells with actinomycin D at 5 pug/ml for 1 hr blocked the antiviral activity of BFS supernatants. The antiviral activity of BFS supernatants, together with the observed susceptibility of the antiviral state to actinomycin D pretreatment indicated that the BFS cell line produced IFN. Three principal types of IFN (a, 3, and y) have been defined on the basis of physicochemical and antigenic differences (10, 11) . The next experiments were performed to characterize the type of IFN produced after PMA stimulation of the BFS cell line. Table 3 shows that the IFN activity produced by BFS cells was sensitive to trypsin and pH 2 treatment but not to heating at 560C for 1 hr. In addition, treatment with rabbit anti-mouse IFN-y antiserum eliminated its antiviral activity. In contrast, treatment of the IFN with goat anti-mouse type I antiserum, which neutralizes type I IFN (IFN-a and IFN-P) had no effect on BFS-derived IFN activity. The anti-type I IFN did, however, neutralize the antiviral activity of poly(I-C)-stimulated L929 cell supernatants. Thus, the IFN produced by BFS cells after stimulation with PMA has the characteristics of IFN-y.
Molecular Weight and Isoelectric Point of BFS-Derived IFN-y. Molecular weight estimates of spleen cell IFN-y by gel filtration have ranged from 20,000 to 60,000, although most reports indicate 40,000-50,000 (11). Our results in Fig. 2 show that the IFN activity elutes from an Ultrogel AcA 54 gel filtra- tion column with an apparent molecular weight of 48,000. The isoelectric point of BFS IFN-y was determined to be between pH 5.5 and 6.0 (Fig. 3) ; this IFN exhibited considerable charge heterogeneity, consistent with the observations made with other IFNs (12) .
Examination for Other Lymphokine Activities of BFS Supernatants. We have examined BFS supernatants for a variety of lymphokine activities in addition to IFN and have found them to be negative for IL-1, IL-2, B cell growth factor, macrophage-granulocyte colony-stimulating factor, T cell-replacing factor (unpublished data), and macrophage-activating factor (M. Meltzer, personal communication). However, IFN-y-containing supernatants obtained from the BFS cell line do induce macrophage Ia antigen expression (unpublished data), which is consistent with previous reports demonstrating this activity for IFN-y (13, 14) .
Synergy Between PMA and EL4 Thymoma Culture Supernatants in the Induction of BFS Interferon. The titers of IFNy produced by the BFS cell line in response to PMA are lower than those obtained after conventional mitogen stimulation of FIG. 3 . Isoelectric point of BFS interferon. IFN (2,500 units) was placed into a 5-50% sucrose gradient containing 2% Ampholines (pH 3.5-10). Three-milliliter fractions were collected for pH and IFN determinations. IFN activity was quantitated by using a virus plaque reduction assay.
Immunology: Benjamin et al. (2) reported that the IL-2-dependent T cell clones producing IFN-y were Thy-1.2+, Lyt-l-, and Lyt-2-. Thus, their cell lines had the same phenotype as the BFS cell line. This is probably explained by the observation that IL-2-dependent T cell lines tend to lose Lyt phenotypic markers upon continued culture (19) . However, the parent CT 6 cell line from which BFS cells were derived was originally a cloned cytotoxic T cell line. Therefore, the origin ofthe BFS cell line was a T cell line that was phenotypically Lyt-1-23+. These data, therefore, support the concept that the Lyt-23+ T lymphocyte is a cellular source of IFN-y.
Controversy also exists in the published literature concerning the interaction of IL-2 and IFN-y. Simon et aL (20) have shown that both IL-2 and IFN-y are able to induce cytotoxic T lymphocytes. Farrar et al. (8) extended these findings by demonstrating that addition ofIL-2 induces IFN-y production in macrophage-depleted mixed lymphocyte cultures. The ability of anti-IFN-yto inhibit the IL-2-induced cytotoxic T cell response suggested a mandatory role of IFN-y in certain IL-2-driven primary responses. Recent data indicate that IFN-y is capable of inducing the expression of T lymphocyte IL-2 receptors (W. Farrar, personal communication). The studies reported here concerning the ability ofIL-2-containing EL4 thymoma culture supernatants to synergistically enhance the production of IFNy by BFS cells further suggest a complex interplay among various factors in the induction of IFN-y. In contrast to our findings, Marcucci et al. (2) have reported that IL-2-dependent T cell clones produced IFN-y only in the absence of IL-2-containing conditioned medium. The latter results suggest that a component of the conditioned medium may be negatively regulating IFN-y production by activated T cells. Further studies with the BFS cell line at both the genetic level and with purified preparations of lymphokines should be useful in resolving this controversy concerning the relationship between IL-2 and IFNy and in addition should allow the examination of intracellular events involved in the induction of IFN-'y production by these factors.
